OCRA News
OCRFA is now OCRA
(October 1, 2018) We’re shortening our name, to make it easier to say and easier to write. OCRFA is now Ovarian Cancer Research Alliance (OCRA). You can find us at ocrahope…
OCRFA Funded Research Identifies Biomarker Linked to HGSOC Treatment and Survival Outcomes
(September 21, 2018) In an international collaboration funded in part by OCRFA, published recently in Cell, researchers used proteomics, the large-scale study of proteins, to identify an important indicator for treatment and disease-free survival in…
Big Strides Made in Identifying More BRCA1 Mutations
(September 19, 2018) Researchers at the University of Washington recently made a breakthrough in identifying and confirming variants of the BRCA1 mutation, a gene mutation that increases a woman’s risk of breast and ovarian cancers…
Exploring the Importance of Glycogen in Cancer Metastasis
(September 14, 2018) A study published in Cell Metabolism explores the use of glycogen by ovarian cancer tumor cells, specifically in an area where metastasis happens quickly, the omentum…
Support Life-Saving Research for Ovarian Cancer Awareness Month
We need your help this September. Ovarian cancer is the fifth leading cause of cancer death among women, and is the deadliest of gynecologic cancers. #ResearchMatters. Research is the key to defeating this devastating disease…
New Clues on the Origins of Ovarian Cancer
(August 30, 2018) Researchers at Brigham and Women’s Hospital in Boston have found new clues to the origin of high-grade serous carcinoma (HGSC)…
OCRA’s Advocate Leader Program is now open. Apply today.
Be a voice for the ovarian cancer community. Update: The deadline to apply for our 2019 Advocate Leader program has now passed. (August 28, 2018) Registration is now open for our 2019 Advocate Leader program…
Non-BRCA Genes Associated with Breast and Ovarian Cancers Identified and Confirmed
(August 24, 2018) A recent study, published in JAMA Oncology, shed light on non-BRCA gene associations to breast and ovarian cancers…
Women with Medicare Found to Have Low Genetic Testing Rates
(August 23, 2018) Researchers from Vanderbilt Institute for Clinical and Translational Research recently conducted a study which focused on Medicare Part B recipients, those above the age of 65 or disabled, who were eligible for genetic testing…
Mutation Patterns Predict Survival and Treatment Resistance in Patients
(August 22, 2018) Several institutions in the UK recently published their project on finding patterns in DNA mutations. The tumors of 117 women, all of whom were diagnosed with high grade serous ovarian cancer, were processed by computer algorithms…
The new Super September, coming September 27-28th!
Maybe you attended Super Saturday in the Hamptons in the past. Or maybe you always wanted to but could never make it out there…
Analgesic Use Has Positive Effect in Ovarian Cancer Patients
(July 30, 2018) Recently, two retrospective studies were published about the effects of analgesics, or pain relievers, on ovarian cancer…